Ventria owns product and enabling technology rights from its internal
development effort and by license, assignment, or exclusive option
agreements as follows:
5 issued United States patents relating to protein expression
and products
4 foreign patents relating to protein expression and products
Over 10 filings relating to ExpressTec
Over 10 filings for the products, their formulations, and uses
